文献速递产科

产后血压普适监测项目的实施:可行性与结局

Implementation of a universal postpartum blood pressure monitoring program: feasibility and outcomes.
PubMed 文献 · Am J Obstet Gynecol MFM · 2022-03-10

本研究为前瞻性观察研究,纳入2020年7月至2021年6月本院出院且既往无高血压疾病的产后女性,实施患者驱动的居家血压监测项目,护士在产后1周电话随访血压及子痫前期症状。作者认为该方案可行,可能利用现有资源整合,且新发产后高血压疾病发生率可能高于既往回顾性队列评估。

要点

  • 产后1周护士电话随访血压及子痫前期症状的患者驱动居家血压监测方案可行。
  • 1192例中222例(19%)初始血压升高,8%可能新诊断妊娠期高血压疾病,0.7%为重度高血压。
  • 血压升高者更多为非西班牙裔黑人及孕早期体重指数较高者。

核心结论

  • 患者驱动的产后血压监测项目可行,可能利用现有资源整合;新发产后妊娠期高血压疾病发生率可能高于既往回顾性队列评估,作者认为对所有女性进行更密切的患者驱动居家血压监测可能有作用,尤其是有危险因素或资源有限时。

研究设计与样本

  • 前瞻性观察研究,纳入2020年7月至2021年6月本院出院且既往未诊断高血压的产后女性,制定并遵循临床算法,出院时提供教育材料,护士在产后1周电话随访血压及子痫前期症状,记录母亲人口学特征和分娩结局。

主要发现

  • 剩余1192例中222例(19%)初始血压升高,其中98例复查再次血压升高,17例转诊急诊科评估,8例诊断为重度子痫前期,其余建议至产科提供者随访并纳入本院远程血压管理项目。
  • 1192例女性中8%可能新诊断妊娠期高血压疾病,0.7%有重度高血压;血压升高者更多为非西班牙裔黑人且孕早期体重指数高于无血压升高者。

临床怎么用

  • 本研究中心的做法是向接受部分产前检查远程进行的女性发放血压袖带,为所有女性提供产后测量血压的机会。
  • 作者认为患者驱动的产后血压监测项目可行,可整合现有资源,对所有女性进行更密切的监测可能有作用,尤其有危险因素或资源有限时。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: New-onset postpartum preeclampsia has a higher risk of maternal morbidity and mortality than preeclampsia with antepartum onset, underscoring the need for earlier identification of elevated blood pressure among patients with this condition. Given the decrease in healthcare engagement, which is typical of the postpartum period, new-onset postpartum hypertension often goes unrecognized. Currently, there are no recommendations for universal postpartum blood pressure surveillance in women without hypertensive disorders of pregnancy. With the shift to telemedicine because of the COVID-19 pandemic, our institution's approach was to distribute blood pressure cuffs to women receiving any portion of their prenatal care virtually, thus also providing access to an opportunity for blood pressure measurement during the postpartum period for all women. OBJECTIVE: To explore the feasibility of a patient-driven universal postpartum home blood pressure monitoring program in women without a previous diagnosis of a hypertensive disorder. STUDY DESIGN: This was a prospective observational study of all postpartum women who were discharged from our institution from July 2020 through June 2021 and who were not previously identified to have hypertension. A clinical algorithm was developed and followed. All the women received discharge educational materials and were called at a 1-week interval by a nurse to review blood pressure and preeclampsia symptoms. The maternal demographics and delivery outcomes were recorded. RESULTS: Of the 10,092 deliveries during the study period, 5959 (59%) were successfully contacted. 352 were excluded, as they did not deliver at the primary hospital; 1052 (18%) had a previous hypertensive disorder of pregnancy diagnosis; 1522 (26%) did not have a blood pressure cuff; and 1841 (31%) planned to take their blood pressure at a later time. Precautions and blood pressure parameters were given to this last group. Of the remaining 1192, 222 (19%) had an initial elevated blood pressure. Of these, 98 had a second elevated blood pressure on recheck; 17 were referred to the emergency room for evaluation, with 8 being diagnosed with severe preeclampsia; and the remainder were recommended to follow with their obstetrical provider and enrolled in our institution's remote blood pressure management program. Of the 1192 women, 8% potentially had a new diagnosis of a hypertensive disorder of pregnancy, with 0.7% having severe hypertension. Women with elevated blood pressures were more likely to be of non-Hispanic Black race and have a higher early pregnancy body mass index than those without elevated blood pressures. CONCLUSION: Our study indicates that a patient-driven postpartum blood pressure monitoring program is feasible and may be incorporated using existing resources. In addition, our findings suggest that the incidence of new-onset postpartum hypertensive disorders of pregnancy may be higher than previously assessed in retrospective cohorts. Thus, there may be a role for closer surveillance of all women with patient-driven home blood pressure monitoring, particularly those with risk factors or in the setting of limited resources.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Hacker FM, Jeyabalan A, Quinn B, et al. Implementation of a universal postpartum blood pressure monitoring program: feasibility and outcomes. Am J Obstet Gynecol MFM. 2022. PMID: 35283352. doi:10.1016/j.ajogmf.2022.100613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。